|
(BS272) |
Sinus arrest during ajmaline challenge in an adolescent with Brugada syndrome carrying a novel loss-of-function mutation in the SCN5A gene |
| |
|
J. Müller-Leisse, K. Sanner, C. Zormpas, P. M. Plank, T. König, D. Duncker, A. Leffler, C. G. Veltmann (Hannover) |
|
(BS273) |
Endo- and epicardial mapping of spontaneous ventricular fibrillation during acute myocardial infarction in a porcine model |
| |
|
S. M. Sattler, E. Z. Hesselkilde, M. Orini, T. Jespersen, J. Tfelt-Hansen (Kopenhagen, Copenhagen, DK; London, UK) |
|
(BS274) |
Optimized assessment of ventricular vulnerability with a modified programmed electrical stimulation protocol after myocardial ischemia and reperfusion in mice |
| |
|
B. Bartsch, L. Clasen, S. Angendohr, A. Fürnkranz, M. Kelm, N. Klöcker, H. Makimoto, S. Wintrich Enkel (Düsseldorf) |
|
(BS275) |
Selective inhibition of sodium channel isoform NaV1.8 reduces proarrhythmic cellular triggers |
| |
|
P. Bengel, S. Ahmad, P. Tirilomis, N. Dybkova, L. S. Maier, G. Hasenfuß, S. T. Sossalla (Göttingen, Regensburg) |
|
(BS276) |
High and low affinity inhibitors of the atrial two-pore-domain (K2P) potassium channel TASK-1 share one common drug binding site |
| |
|
F. Wiedmann, A. Ratte, M. Waibel, M. Kraft, D. Thomas, P. Anand, W. Wenzel, H. A. Katus, C. Schmidt (Heidelberg, Eggenstein-Leopoldshafen) |
|
(BS277) |
Carnitine and its metabolites exert beneficial QT- / APD-prolonging effects in transgenic short QT syndrome 1 rabbits |
| |
|
L. Mettke, K. Michaelides, I. Bodi, S. Perez-Feliz, M. Brunner, C. Bode, K. Odening, für die Studiengruppe: XXX (Freiburg im Breisgau) |